Description: 908 Devices is democratizing laboratory mass spectrometry with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, pharma / biopharma, forensics and adjacent markets. The Company is headquartered in the heart of Boston, where it conducts research, designs and manufactures innovative products that bring together the power of mass spectrometry, microfluidic separations, software automation, and machine learning.
Home Page: www.908devices.com
MASS Technical Analysis
645 Summer Street
Boston,
MA
02210
United States
Phone:
857 254 1500
Officers
| Name | Title |
|---|---|
| Dr. Kevin J. Knopp Ph.D. | Co-Founder, CEO, Pres & Director |
| Dr. Christopher David Brown Ph.D. | Co-Founder, CTO, VP of R&D and Member of Scientific Advisory Board |
| Mr. Steve Araiza | Co-Founder |
| Mr. Andrew Bartfay | Co-Founder & Director of Hardware Devel. |
| Mr. Michael Jobin | Co-Founder & Director of Product Devel. |
| Dr. Scott Miller Ph.D. | Co-founder & Director of MS Engineering |
| Mr. Joseph H. Griffith IV | CFO & Treasurer |
| Mr. Michael S. Turner Esq., J.D. | VP, Sec. & Gen. Counsel |
| Ms. Maura Fitzpatrick | VP of Product Management & Marketing |
| Dr. Trent A. Basarsky Ph.D. | VP of Corp. Devel. |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.4363 |
| Price-to-Sales TTM: | 5.3919 |
| IPO Date: | 2020-12-18 |
| Fiscal Year End: | December |
| Full Time Employees: | 177 |